Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 5

Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide

Authors Carl E Stafstrom

Published 23 October 2009 Volume 2009:5 Pages 547—551


Review by Single-blind

Peer reviewer comments 3

Carl E Stafstrom

Section of Pediatric Neurology, Departments of Neurology and Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Objective: This review summarizes the treatment of Lennox-Gastaut syndrome, an intractable epileptic encephalopathy of early childhood. In particular, the review focuses on rufinamide, a recently released anticonvulsant medication with reported effectiveness in this epilepsy syndrome.

Methods: A systematic literature search (PubMed) was performed to review the existing literature pertaining to the treatment of Lennox-Gastaut syndrome as well as studies involving rufinamide as an anticonvulsant medication.

Results: The published literature to date documents a beneficial effect of rufinamide on children over 4 years old with Lennox-Gastaut syndrome. Studies indicate a significant decrease in tonic and atonic seizure frequency as well as total seizure frequency compared to placebo-treated children. Rufinamide appears to be well tolerated and a safe medication, somnolence and vomiting being the most common side effects.

Conclusions: Rufinamide is a promising adjunctive therapy for Lennox-Gastaut syndrome, an intractable childhood epilepsy. To ensure its optimal effectiveness, clinicians must be familiar with the medication’s clinical response profile and potential for adverse effects.

Keywords: pediatric, epilepsy, epileptic encephalopathy, Lennox-Gastaut syndrome, rufinamide

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Evaluation of calcified carotid atheroma on panoramic radiographs and Doppler ultrasonography in an older population

Atalay Y, Asutay F, Agacayak KS, Koparal M, Adali F, Gulsun B

Clinical Interventions in Aging 2015, 10:1121-1129

Published Date: 8 July 2015

Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity

Gozzi GJ, Bouaziz Z, Winter E, Daflon-Yunes N, Honorat M, Guragossian N, Marminon C, Valdameri G, Bollacke A, Guillon J, Pinaud N, Marchivie M, Cadena SM, Jose J, Le Borgne M, Di Pietro A

Drug Design, Development and Therapy 2015, 9:3481-3495

Published Date: 3 July 2015

Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities

Bagheri A, Kamalidehghan B, Haghshenas M, Azadfar P, Akbari L, Sangtarash MH, Vejdandoust F, Ahmadipour F, Meng GY, Houshmand M

Drug Design, Development and Therapy 2015, 9:2627-2634

Published Date: 13 May 2015

Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients

Huang YS, Feng YC, Zhang J, Bai L, Huang W, Li M, Sun Y

Clinical Interventions in Aging 2015, 10:81-87

Published Date: 19 December 2014

Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia

Kikuchi YS, Sato W, Ataka K, Yagisawa K, Omori Y, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2014, 10:1973-1978

Published Date: 15 October 2014

Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders

Cera N, Bifolchetti S, Martinotti G, Gambi F, Sepede G, Onofrj M, Di Giannantonio M, Thomas A

Neuropsychiatric Disease and Treatment 2014, 10:1093-1101

Published Date: 17 June 2014

Neurophysiological correlates of response inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials

Petit G, Cimochowska A, Kornreich C, Hanak C, Verbanck P, Campanella S

Neuropsychiatric Disease and Treatment 2014, 10:1025-1037

Published Date: 9 June 2014

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan

Sugawara N, Yasui-Furukori N, Tomita T, Furukori H, Kubo K, Nakagami T, Kaneko S

Neuropsychiatric Disease and Treatment 2014, 10:427-432

Published Date: 28 February 2014

Measuring quality of sleep and autonomic nervous function in healthy Japanese women

Sato M, Yasuhara Y, Tanioka T, Iwasa Y, Miyake M, Yasui T, Tomotake M, Kobayashi H, Locsin RC

Neuropsychiatric Disease and Treatment 2014, 10:89-96

Published Date: 17 January 2014